Synthesis and identification of new sacubitril derivatives as lead compounds for antibacterial, antifungal and antitubercular (TB) activities against dormant tuberculosis-Reference-Cited by-同舟云学术

Synthesis and identification of new sacubitril derivatives as lead compounds for antibacterial, antifungal and antitubercular (TB) activities against dormant tuberculosis

Published:2023 Issue:20 Volume:13 Page:13540-13546
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Bhargavi Dodda¹,Konduri Srihari²,Prashanth Jyothi³^ORCID,Pulipati Sowjanya⁴,Praneeth K. K.⁵^ORCID,Sireesha Malladi¹,Rao Koya Prabhakara¹^ORCID

Affiliation:

1. New Generation Materials Lab (NGML), Department of Chemistry, School of Applied Science and Humanities, Vignan's Foundation for Science Technology and Research (VFSTR) (Deemed to be University), Vadlamudi, Guntur-522 213, Andhra Pradesh, India

2. Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA

3. Department of Physics, Kakatiya University, Warangal, 506009, Telangana, India

4. Department of Pharmaceutical Biotechnology, Vignan Pharmacy College, Vadlamudi, Guntur-522213, Andhra Pradesh, India

5. Somaiya Vidyavihar University, Vidyavihar, Mumbai-400077, Maharashtra, India

Abstract

We identified twenty-two new sacubitril derivatives (5a–v) as lead compounds for various biologically active targets.

Funder

Science and Engineering Research Board

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA00713H

Reference33 articles.

1. Synthesis, Isolation, and Analysis of Stereoisomers of Sacubitril

2. Dicarboxylic Acid Dipeptide Neutral Endopeptidase Inhibitors

3. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

4. Synthesis of a Precursor to Sacubitril Using Enabling Technologies

5. US Food and Drug Administration , Development Approval Process/Drug Innovation , Novel Drugs Summary , 2015 , http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm474696.htm